HCA Healthcare, Inc. $HCA Shares Acquired by PensionDanmark Pensionsforsikringsaktieselskab

PensionDanmark Pensionsforsikringsaktieselskab increased its holdings in shares of HCA Healthcare, Inc. (NYSE:HCA) by 6.9% in the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 41,916 shares of the company’s stock after purchasing an additional 2,700 shares during the period. PensionDanmark Pensionsforsikringsaktieselskab’s holdings in HCA Healthcare were worth $16,343,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other hedge funds and other institutional investors also recently added to or reduced their stakes in the company. Brighton Jones LLC acquired a new position in shares of HCA Healthcare in the 4th quarter valued at about $1,021,000. NewEdge Advisors LLC raised its position in HCA Healthcare by 11.9% during the first quarter. NewEdge Advisors LLC now owns 3,859 shares of the company’s stock valued at $1,334,000 after acquiring an additional 409 shares in the last quarter. Sivia Capital Partners LLC boosted its position in HCA Healthcare by 5.5% in the 2nd quarter. Sivia Capital Partners LLC now owns 630 shares of the company’s stock worth $241,000 after purchasing an additional 33 shares in the last quarter. Jump Financial LLC purchased a new position in shares of HCA Healthcare during the 2nd quarter valued at approximately $2,073,000. Finally, Sei Investments Co. boosted its holdings in HCA Healthcare by 56.3% during the second quarter. Sei Investments Co. now owns 136,589 shares of the company’s stock worth $52,328,000 after buying an additional 49,214 shares in the last quarter. 62.73% of the stock is owned by institutional investors and hedge funds.

HCA Healthcare Stock Performance

NYSE HCA opened at $412.80 on Friday. HCA Healthcare, Inc. has a one year low of $353.99 and a one year high of $556.52. The business has a fifty day moving average price of $389.00 and a 200 day moving average price of $448.75. The company has a market cap of $89.37 billion, a P/E ratio of 13.82, a P/E/G ratio of 1.42 and a beta of 1.10.

HCA Healthcare (NYSE:HCA) last issued its earnings results on Friday, July 24th. The company reported $7.59 EPS for the quarter, beating analysts’ consensus estimates of $7.56 by $0.03. HCA Healthcare had a net margin of 8.77% and a negative return on equity of 244.79%. The business had revenue of $20.23 billion during the quarter, compared to analysts’ expectations of $19.76 billion. During the same period in the prior year, the business earned $6.84 earnings per share. The company’s quarterly revenue was up 8.7% compared to the same quarter last year. As a group, sell-side analysts predict that HCA Healthcare, Inc. will post 29.45 EPS for the current fiscal year.

HCA Healthcare Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Wednesday, September 30th. Stockholders of record on Wednesday, September 16th will be given a $0.78 dividend. The ex-dividend date is Wednesday, September 16th. This represents a $3.12 dividend on an annualized basis and a dividend yield of 0.8%. HCA Healthcare’s dividend payout ratio is 10.45%.

Analyst Upgrades and Downgrades

A number of research analysts have weighed in on HCA shares. Truist Financial decreased their price objective on shares of HCA Healthcare from $535.00 to $495.00 and set a “buy” rating for the company in a research report on Monday, July 27th. Sanford C. Bernstein reaffirmed a “market perform” rating on shares of HCA Healthcare in a research note on Wednesday, July 15th. Wells Fargo & Company lifted their price target on shares of HCA Healthcare from $369.00 to $381.00 and gave the company an “equal weight” rating in a research note on Monday, August 3rd. Raymond James Financial set a $528.00 price objective on shares of HCA Healthcare in a report on Tuesday, July 7th. Finally, Barclays reduced their price target on shares of HCA Healthcare from $402.00 to $387.00 and set an “equal weight” rating for the company in a research report on Monday, July 27th. Fourteen investment analysts have rated the stock with a Buy rating, eight have assigned a Hold rating and one has given a Sell rating to the stock. According to MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and an average price target of $465.59.

HCA Healthcare Profile

HCA Healthcare is a for?profit operator of healthcare facilities headquartered in Nashville, Tennessee. Founded in 1968, the company owns and operates a network of hospitals and related healthcare facilities and has grown through organic expansion and acquisitions to become a large provider of inpatient and outpatient services.

The company’s core activities include the operation of acute care hospitals, freestanding surgical and emergency centers, and outpatient clinics. HCA’s services encompass inpatient care, surgical services, emergency medicine, diagnostic imaging and laboratory testing, and various outpatient and ambulatory care offerings.